Literature DB >> 33021322

Itch Relief in Atopic Dermatitis: Comparison of Narrowband Ultraviolet B Radiation and Cyclosporine Treatment.

Andrzej Jaworek1, Krystyna Szafraniec, Magdalena Jaworek, Łukasz Matusiak, Anna Wojas-Pelc, Jacek C Szepietowski.   

Abstract

Entities:  

Keywords:  UVB; atopic dermatitis; cyclosporine; pruritus; itch

Mesh:

Substances:

Year:  2020        PMID: 33021322      PMCID: PMC9274909          DOI: 10.2340/00015555-3652

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  14 in total

1.  Sequential treatment of severe atopic dermatitis with cyclosporin A and low-dose narrow-band UVB phototherapy.

Authors:  V Brazzelli; F Prestinari; M G Chiesa; R G Borroni; M Ardigò; G Borroni
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

2.  Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis.

Authors:  Franz J Legat; Angelika Hofer; Eva Brabek; Franz Quehenberger; Helmut Kerl; Peter Wolf
Journal:  Arch Dermatol       Date:  2003-02

3.  Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis.

Authors:  H Granlund; P Erkko; A Remitz; T Langeland; P Helsing; M Nuutinen; S Reitamo
Journal:  Acta Derm Venereol       Date:  2001 Jan-Feb       Impact factor: 4.437

4.  Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch.

Authors:  Adam Reich; Claudia Riepe; Zografia Anastasiadou; Karolina Mędrek; Matthias Augustin; Jacek C Szepietowski; Sonja Ständer
Journal:  Acta Derm Venereol       Date:  2016-11-02       Impact factor: 4.437

5.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

6.  Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.

Authors:  A Wollenberg; S Barbarot; T Bieber; S Christen-Zaech; M Deleuran; A Fink-Wagner; U Gieler; G Girolomoni; S Lau; A Muraro; M Czarnecka-Operacz; T Schäfer; P Schmid-Grendelmeier; D Simon; Z Szalai; J C Szepietowski; A Taïeb; A Torrelo; T Werfel; J Ring
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-05       Impact factor: 6.166

7.  Favorable clinical response by pre-prandial administration of low-dose ciclosporin to severe adult atopic dermatitis.

Authors:  Satoshi Nakamura; Keiko Takeda; Yoshio Hashimoto; Kaoru Nishi; Hidetoshi Takahashi; Toshihiro Mizumoto; Hajime Iizuka
Journal:  J Dermatolog Treat       Date:  2011-01-22       Impact factor: 3.359

8.  The diagnostic validity of the Athens Insomnia Scale.

Authors:  Constantin R Soldatos; Dimitris G Dikeos; Thomas J Paparrigopoulos
Journal:  J Psychosom Res       Date:  2003-09       Impact factor: 3.006

9.  Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.

Authors:  T Gambichler; N Othlinghaus; N S Tomi; T Holland-Letz; S Boms; M Skrygan; P Altmeyer; A Kreuter
Journal:  Br J Dermatol       Date:  2008-12-11       Impact factor: 9.302

10.  Antipruritic effect of oral cyclosporin A in atopic dermatitis.

Authors:  C F Wahlgren; A Scheynius; O Hägermark
Journal:  Acta Derm Venereol       Date:  1990       Impact factor: 4.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.